
Sunil Singhal
Associate Program Director · University of Pennsylvania School of Medicine
Credentials: · · · · · ·
History
- Present
Perelman School of Medicine at the University of Pennsylvania · University of Pennsylvania School of Medicine
- Present
Thoracic Surgery Division · University of Pennsylvania School of Medicine
- Present
Division of Thoracic Surgery · University of Pennsylvania School of Medicine
- 2007
Centre Chirurgical Marie Lannelongue Hospital
- 1998–2005
Research
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Journal of Clinical Investigation · 2014 · Last of 14 authors · 559 citations
Evolving options in the management of esophageal perforation
Systematic review or meta-analysis · The Annals of Thoracic Surgery · 2004 · 534 citations
Cancer Cell · 2016 · First of 15 authors · 404 citations

61 papers · 57 as a resident
- GK
52 papers · 45 as a resident

51 papers

46 papers
- FA
42 papers · 40 as a resident

34 papers · 34 as a resident

24 papers

24 papers · 21 as a resident
Grants
- 2025–2030
Clinical Translation of a Choline-Targeted NIR Dye to Guide Lung Cancer Resection
National Cancer Institute · R01
PI · $1.3M · University of Pennsylvania
- 2022–2027
Intraoperative Near Infrared Molecular Imaging of Lung Cancer
National Cancer Institute · P01
Contact PI · $8.3M · University of Pennsylvania
- 2022–2027
National Cancer Institute · R01
PI · $2.4M · University of Pennsylvania
- 2022–2024
National Cancer Institute · R44
PI · $2M · Vergent Bioscience, Inc.
Clinical trials
- 2022
OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
Principal investigator · Withdrawn · Phase 1
Abramson Cancer Center at Penn Medicine
- 2022
Principal investigator · Completed · Phase 2
OncoNano Medicine, Inc.
- 2020–2022
Intraoperative Imaging of Pulmonary Nodules by SGM-101
Principal investigator · Completed · Phase 1
Sunil Singhal
- 2020–2021
ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting
Principal investigator · Completed · Phase 3
On Target Laboratories, LLC


